4.10
price down icon5.31%   -0.23
after-market 시간 외 거래: 4.06 -0.04 -0.98%
loading
전일 마감가:
$4.33
열려 있는:
$4.33
하루 거래량:
88,923
Relative Volume:
1.06
시가총액:
$43.31M
수익:
$1.93M
순이익/손실:
$-7.96M
주가수익비율:
-0.00116
EPS:
-3530.8178
순현금흐름:
$-36.78M
1주 성능:
+2.50%
1개월 성능:
-14.23%
6개월 성능:
-59.61%
1년 성능:
-62.69%
1일 변동 폭
Value
$4.06
$4.49
1주일 범위
Value
$3.93
$4.71
52주 변동 폭
Value
$3.39
$16.00

아발로 테라퓨틱스 Stock (AVTX) Company Profile

Name
명칭
Avalo Therapeutics Inc
Name
전화
410-522-8707
Name
주소
1500 LIBERTY RIDGE DRIVE, WAYNE
Name
직원
23
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
AVTX's Discussions on Twitter

AVTX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
AVTX
Avalo Therapeutics Inc
4.10 43.31M 1.93M -7.96M -36.78M -3,530.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

아발로 테라퓨틱스 Stock (AVTX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-02 재개 H.C. Wainwright Buy
2025-03-25 개시 Jefferies Buy
2025-03-25 개시 Stifel Buy
2025-02-28 개시 Piper Sandler Overweight
2025-02-21 개시 Wedbush Outperform
2024-12-19 개시 BTIG Research Buy
2024-10-24 개시 H.C. Wainwright Neutral
2024-04-16 업그레이드 Oppenheimer Perform → Outperform
2021-09-24 개시 RBC Capital Mkts Outperform
모두보기

아발로 테라퓨틱스 주식(AVTX)의 최신 뉴스

pulisher
Jun 05, 2025

Avalo Therapeutics Signs New Sales Agreement - TipRanks

Jun 05, 2025
pulisher
Jun 04, 2025

Avalo Therapeutics Highlights AVTX-009 Potential in HS Market - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Invests $168,000 in Avalo Therapeutics, Inc. (NASDAQ:AVTX) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Avalo Therapeutics (NASDAQ:AVTX) Upgraded at HC Wainwright - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

H.C. Wainwright upgrades Avalo Therapeutics stock to buy - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Avalo Therapeutics assumed with a Buy at H.C. Wainwright - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

H.C. Wainwright upgrades Avalo Therapeutics stock to buy By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

AVTX: Avalo Therapeutics Receives Buy Rating with $15 Target Pri - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Avalo Therapeutics (AVTX) Receives Buy Rating from H.C. Wainwright | AVTX Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Cardax (OTCMKTS:CDXI) and Avalo Therapeutics (NASDAQ:AVTX) Head-To-Head Analysis - Defense World

Jun 02, 2025
pulisher
May 31, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Update - Defense World

May 31, 2025
pulisher
May 27, 2025

Avalo Therapeutics to Participate in Upcoming Investor Conferenc - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Avalo Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

May 27, 2025
pulisher
May 17, 2025

Brokerages Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) Target Price at $33.00 - Defense World

May 17, 2025
pulisher
May 16, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Shares Bought by Tower Research Capital LLC TRC - Defense World

May 16, 2025
pulisher
May 13, 2025

Strong Cash Position Secures AVTX Through 2027 | AVTX Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Avalo Therapeutics Reports Improved Financial Performance - TipRanks

May 13, 2025
pulisher
May 12, 2025

Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates - GlobeNewswire

May 12, 2025
pulisher
May 12, 2025

Avalo Therapeutics reports Q1 EPS ($1.25) vs. ($141.14) last year - TipRanks

May 12, 2025
pulisher
May 12, 2025

Avalo Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

AVTX Advances Phase 2 LOTUS Trial, Targets 2026 Data | AVTX Stoc - GuruFocus

May 12, 2025
pulisher
May 12, 2025

AVALO THERAPEUTICS Earnings Results: $AVTX Reports Quarterly Earnings - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Avalo Reports First Quarter 2025 Financial Results and Recent Bu - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Avalo Therapeutics Announces Leadership Change and Updates on AVTX-009 Phase 2 Trial for Hidradenitis Suppurativa - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Avalo Therapeutics, Inc. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 12, 2025

Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates - GlobeNewswire Inc.

May 12, 2025
pulisher
May 10, 2025

Avalo Therapeutics (AVTX) Expected to Announce Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
May 08, 2025

Avalo Therapeutics Updates on AVTX-009 and LOTUS Trial - TipRanks

May 08, 2025
pulisher
May 07, 2025

15,323 Shares in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Acquired by Marshall Wace LLP - Defense World

May 07, 2025
pulisher
May 06, 2025

When the Price of (AVTX) Talks, People Listen - news.stocktradersdaily.com

May 06, 2025
pulisher
May 06, 2025

Avalo Therapeutics Enters $75 Million Sales Agreement With TD Cowen For Common Stock Offering - marketscreener.com

May 06, 2025
pulisher
May 02, 2025

Geode Capital Management LLC Increases Position in Avalo Therapeutics, Inc. (NASDAQ:AVTX) - Defense World

May 02, 2025
pulisher
Apr 30, 2025

Avalo Therapeutics to Participate in The Citizens Life Sciences Conference - The Manila Times

Apr 30, 2025
pulisher
Apr 23, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Up 20.3% in March - Defense World

Apr 23, 2025
pulisher
Apr 22, 2025

60,000 Shares in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Purchased by Bank of Montreal Can - Defense World

Apr 22, 2025
pulisher
Apr 22, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives $33.00 Average PT from Brokerages - Defense World

Apr 22, 2025
pulisher
Apr 16, 2025

Avalo Therapeutics (AVTX) Sees New Options Listings for April | AVTX Stock News - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Seven new option listings and one option delisting on April 16th - TipRanks

Apr 16, 2025
pulisher
Apr 15, 2025

Avalo Therapeutics Reports 2024 Financial Results - TipRanks

Apr 15, 2025
pulisher
Apr 09, 2025

Advanced Cancer Pain Management Therapeutics Market Size in 7MM - openPR.com

Apr 09, 2025
pulisher
Apr 04, 2025

(AVTX) On The My Stocks Page - news.stocktradersdaily.com

Apr 04, 2025
pulisher
Apr 04, 2025

AVTX stock touches 52-week low at $5.98 amid market challenges - Investing.com Australia

Apr 04, 2025
pulisher
Apr 04, 2025

AVTX stock touches 52-week low at $5.98 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Mar 29, 2025

Avalo Therapeutics (NASDAQ:AVTX) Coverage Initiated at Stifel Nicolaus - MarketBeat

Mar 29, 2025
pulisher
Mar 28, 2025

Avalo Therapeutics (AVTX) to Release Earnings on Friday - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Analysts Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) Target Price at $33.00 - Defense World

Mar 28, 2025
pulisher
Mar 26, 2025

Avalo Therapeutics names new Chairman amid growth phase By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Avalo Therapeutics Names Michael Heffernan as Board Chairman - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Avalo Therapeutics Appoints Michael Heffernan As Chairman Of The Board - MarketScreener

Mar 26, 2025

아발로 테라퓨틱스 (AVTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
자본화:     |  볼륨(24시간):